Delivery Order SPE2DB22D1017-SPE2DB25FYSFA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $35,537.32. This firm fixed-price delivery order, which is non-set-aside, was competitively awarded and has an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is valued at $42,130.29 and is scheduled for completion by November 5, 2025. The contract carries no set-aside designation, reflecting open competition among qualified vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This competitively awarded, firm fixed-price delivery order has a ceiling value of $17,461.55 and an ultimate completion date of September 17, 2025. The contract carries no set-aside designation, indicating it was competed among all eligible vendors. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $18,343.17 on November 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets in packages of 30 units. The contract represents a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $18,577.92, with an ultimate completion date of August 15, 2025. The contract is non-set-aside and represents a competitive award under the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $38,755.71 and an ultimate completion date of November 10, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $10,334.55. This firm fixed price, non-set-aside contract is scheduled for ultimate completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets in 30-unit packages. This is a firm fixed-price delivery order with a ceiling value of $1,548.16, with an ultimate completion date of April 25, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,096.32 and is scheduled for completion by August 1, 2025. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSFADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $16,491.43 and an ultimate completion date of September 29, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its established capability to fulfill federal medical supply needs across multiple therapeutic domains, serving critical customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 9/28/25 |